Class / Patent application number | Description | Number of patent applications / Date published |
424040000 | COMBUSTIBLE OR CHEMICALLY REACTIVE TO PRODUCE A SMOKE, MIST OR AEROSOL | 24 |
20080199408 | Azeotropic fumigant compositions of methyl iodide - Azeotropic and azeotrope-like compositions of methyl iodide and at least one fluorocarbon or hydrofluorocarbon such as 1,1,1,3,3-pentafluoropropane (HFC-245fa). The compositions are present as a gas, at temperatures of about 30° C. or below. The inventive compositions serve as a non-ozone-depleting gaseous fumigant which is useful in a variety of applications, in place of methyl bromide. These compositions serve as a drop-in replacement for gaseous methyl bromide, providing the benefits of a methyl iodide fumigant while also utilizing existing methyl bromide equipment. | 08-21-2008 |
20090041675 | Organic compounds - A medicament comprising, separately or together, (A) a compound of formula I | 02-12-2009 |
20090041676 | Targeted Delivery of Lidocaine and Other Local Anesthetics and A Method For Treatment of Cough, Asthma and Tussive Attacks - An anti-tussive nebulized solution for targeted delivery of lidocaine into conducting and central airways. A method for treatment of cough and tussive attacks or episodes using said lidocaine solution. A nebulized lidocaine solution administered in daily dose from about 10 mg to 80 mg of lidocaine dissolved in a saline and nebulized into an aerosol having a mass median aerodynamic diameter 3 μm to 10 μm and a geometric standard deviation less than 1.7 using an electronic nebulizer. | 02-12-2009 |
20090041677 | AZEOTROPE-LIKE COMPOSITIONS OF 1-CHLORO-3,3,3-TRIFLUOROPROPENE AND METHYL IODIDE - An azeotropic or azeotrope-like composition comprising a mixture of methyl iodide, 1-chloro-3,3,3,-trifluoropropene, and optionally one or more of fluorocarbons and/or hydrofluorocarbons. The compositions are present as a gas, at temperatures of about 30° C. or below. The inventive compositions serve as a non-ozone-depleting gaseous fumigant which is useful in a variety of applications, in place of methyl bromide. These compositions serve as a drop-in replacement for gaseous methyl bromide, providing the benefits of a methyl iodide fumigant while also utilizing existing methyl bromide equipment. | 02-12-2009 |
20090092556 | AZEOTROPE-LIKE COMPOSITIONS OF DIFLUOROMETHANE AND TRIFLUOROIODOMETHANE - Provided are azeotrope-like compositions comprising difluoromethane and trifluoroiodomethane and uses thereof, including use in refrigerant compositions, refrigeration systems, blowing agent compositions, and aerosol propellants. | 04-09-2009 |
20090162294 | DISPOSABLE INHALER - The inventive inhaler functions in a similar way to a cigarette but without the formation of carcinogenic substances and carbon monoxide, as instead of tobacco or other substances containing carbon, metallic components of a combustion body ( | 06-25-2009 |
20090180968 | Metal Coordination Complexes Of Volatile Drugs - The present disclosure provides a drug delivery device comprising a housing defining an airway, wherein the airway comprises at least one air inlet and a mouthpiece having at least one air outlet, at least one heated metal substrate disposed within the airway, at least one drug disposed on the at least one heated metal substrate. Drugs that can be complexed with metals or metal salts and could be deposited as thin films on heated metal substrate for generating thermal condensation aerosols are particularly suited. The metal substrate could be electrically or chemically heated. Further, the chemically heated metal source could be activated by an igniter that generates heat or spark. | 07-16-2009 |
20100021392 | Vapor-phase application of spinosyn for the control of pest, and formulations and products utilizing the same - The present invention relates to the vapor-phase application of at least one spinosyn to treat pests including, for example, adult mosquitoes and houseflies. | 01-28-2010 |
20100068154 | Printable Igniters - An igniter comprises at least two conductors in the spaced-apart configuration and an electrically conductive layer bridging the at least two conductors, wherein the conductive layer has an electrical resistance greater than an electrical resistance of the at least two conductors. In one embodiment, the at least two conductors and the electrically conductive layer comprise a conductive ink, which may be the same conductive ink having different dimensions. A supplementary initiator composition may be deposited on or incorporated into the conductive layer. In a process for producing the igniter, the electrically conductive layer and the at least two conductors are printed on a non-electrically conducting substrate. Also disclosed are a method for igniting a combustible composition using the igniter, a method for producing an aerosol drug using the igniter, a method for providing a dose of a drug to a human patient using the igniter, a drug delivery device comprising the igniter and a drug supply unit comprising the igniter. | 03-18-2010 |
20100068155 | Reactant Formulations and Methods for Controlled Heating - Disclosed herein are reactant formulations capable of undergoing an exothermic chemical reaction. The reactant formulations comprise a metal reducing agent, a metal-containing oxidizing agent, and manganese oxide in an amount effective to control a temperature profile of the reactant formulation. The manganese oxide may be, for example and without limitation, MnO, MnO | 03-18-2010 |
20100143264 | COMPOSITIONS FOR AEROSOLIZATION OF HIGHLY CONDUCTIVE SOLUTIONS - Compositions for aerosolization of conductive solutions (preferably highly conductive solutions) by way of electrostatic or electrohydrodynamic spraying are provided. Methods for making and using these compositions and electrostatic and electrohydrodynamic aerosol generators containing these compositions are also provided. | 06-10-2010 |
20100150844 | USE OF 8-QUINOLINOL AND ITS ANALOGS TO TARGET CANCER STEM CELLS - 8-quinolinol (8Q) and derivatives thereof for use in the treatment of proliferative diseases such as cancer, in particular slow metabolizing quiescent cancer stem cells. | 06-17-2010 |
20100166670 | USE OF BOSWELLIC ACID AND ITS DERIVATIVES FOR INHIBITING NORMAL AND INCREASED LEUCOCYTIC ELASTASE OR PLASMIN ACTIVITY - The invention concerns the use of pure boswellic acid, a physiologically acceptable salt, a derivative, a salt of the derivative or a plant preparation containing boswellic acid for preventing and/or combatting diseases which are caused by increased leucocytic elastase or plasmin activity or can be treated by the inhibition of, normal leucocytic elastase or plasmin activity, in human or veterinary medicine. | 07-01-2010 |
20100189661 | POLYMER-BOUND UV ABSORBERS IN PERSONAL CARE COMPOSITIONS - Personal care compositions comprising a polymer-bound UV absorber are described that provide enhanced properties, including customizable UV spectrum protection, broad-spectrum UV spectrum protection, water resistance, and labile UV stabilization. The polymer comprises anhydride functionality, such as maleic anhydride or a derivative thereof, and the UV absorber contains at least one hydroxyl, primary amine, or secondary amine group. | 07-29-2010 |
20100297028 | MEDICAMENT COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES - The present invention relates to new medicament combinations which contain in addition to one or more, preferably one compound of general formula 1 | 11-25-2010 |
20110008264 | METHOD FOR REPELLING A RODENT, METHOD FOR CAPTURING A RODENT AND RODENT REPELLENT - A rodent repelling method which uses smoke. | 01-13-2011 |
20110262367 | INSECTICIDAL GASSING AGENT CONTAINING ACTIVE INGREDIENT IN THE FORM OF A GRANULATE - The present invention relates to novel insecticidal fumigants which are prepared using active substance granules, to the processes for the preparation of such fumigants and to their use for controlling harmful and/or nuisance insects. | 10-27-2011 |
20120315221 | Human sample matching system - Methods and apparatus for a human sample (S), analyzing the sample (S) and then determining a match with a member of the opposite sex is disclosed. In one embodiment, a customer purchases an AromaMatch™ Test Kit ( | 12-13-2012 |
20130209371 | Germ Solve Candle - A candle is provided which includes a unique blend of ingredients that been formulated to reduce a broad spectrum of germs in the area of the candle of the present invention, as well as weakening the spread of infectious contaminates imposed by coughing and sneezing, in the area surrounding the candle of the present invention. | 08-15-2013 |
20140161736 | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY - Compounds of formula (I) described herein act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive or inflammatory diseases. | 06-12-2014 |
20140286877 | COMPOSITIONS COMPRISING SALBUTAMOL SULPHATE - A surfactant-free pharmaceutical composition is described. The composition consists essentially of: (a) a drug component consisting of salbutamol sulphate; and (b) a propellant component consisting essentially of 1,1-difluoroethane (R-152a). A method for preparing the pharmaceutical composition is also described. The pharmaceutical composition can be delivered using a metered dose inhaler (MDI). | 09-25-2014 |
20150037263 | TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FINGOLIMOD - This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject laquinimod as an add-on therapy to or in combination with fingolimod. This invention also provides a package and a pharmaceutical composition comprising laquinimod and fingolimod for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides laquinimod for use as an add-on therapy or in combination with fingolimod in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and fingolimod in the preparation of a combination for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. | 02-05-2015 |
20150313234 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL - Disclosed is a compound represented by formula (1): | 11-05-2015 |
424041000 | Elemental sulfur containing | 1 |
20190142914 | NOVEL FUSION PROTEINS FOR TREATING INFLAMMATORY DISEASES | 05-16-2019 |